Granules Logo
  • Home
  • About Us
    • Overview
    • Business Model
    • Milestones
    • Our Presence
    • Board of Directors
    • Mission, Vision and Values
    • Environment
  • Products
  • Research & Development
    • Product Development
    • R & D Capabilities
  • Infrastructure
    • Capacities and Capabilities
    • Regulatory Approvals
  • Investor Relations
    • Overview
    • Financial Highlights
    • Annual Report
    • Code of Conduct
    • Shareholding Pattern
    • Recent News
  • Contact Us
    • Sales Offices
    • Enquiry Form
    • FAQs
Investor Relations
Overview
Financial Highlights
Annual Report
Code of Conduct
Shareholding Pattern
Recent News
GILW left top curve GILW right top curve
Contact
Granules Investor Enquiry

E-mail:
vijay.ramanavarapu@granulesindia.com
investorrelations@granulesindia.com

GILW left bottom curve GILW right bottom curve

Recent News

  • Granules India Posts Record Revenue for a Quarter: Net Revenue of Rs. 122.40 Cr. Posted for Q3 FY’10

  • Granules Posts Record Revenue, Net Profit Increases 121%

  • Granules donates 10 Lakhs to CM Relief Fund

  • Granules bags the coveted “Fastest Emerging Company from India” Award

  • Granules Signs Material Finished Dosage Contract

  • Granules India posts high profits in Q1 FY'10- Net profit up by 129%

  • Granules India Q2 FY08 Net sales up 5.44 per cent at Rs 53 crore

  • Granules India Limited Posts an increase of 37% in TURNOVER and 35% on NET PROFITS

  • PharmaMatch B.V., and Granules India Limited are pleased to announce the signing of a Memorandum of Understanding.

  • Granules India achieves higher EBITDA.

  • Granules India FY07 Net Profit up 14.61 per cent at Rs 10.59 crs.

  • Granules India invites shareholders approval for IFC investment.

  • Granules India Ltd., is pleased to announce the approval of its facilities in the recently conducted audit by US FDA.

  • HERITAGE and GRANULES enter Into Strategic Alliance for the Development, Supply and Marketing.

Sitemap   |   FAQs
© Granules India Limited. All rights reserved.